Inflammatory ResponseNCT05596500
Blueberry-protein Supplementation and Exercise
A study testing Blueberry-protein gel and Blueberry gel in people with Inflammatory Response, run by Appalachian State University at 1 site in United States.
Trial summary
This study is the human clinical trial component of an SBIR grant with Sinnovatek (funded). Cyclists (n=20) will consume a blueberry-protein, blueberry, or placebo supplement for 2 weeks prior to cycling for 2.5 h at high intensity. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Inflammatory Response
- What is being tested?
- Blueberry-protein gel and Blueberry gel
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 21 participants
- Where
- 1 siteUnited States
- Study dates
- 15 Jan 2023to 1 Jun 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Male or female.
- Ages 18-65 years.
- Non-smoker.
- Regularly compete in road races (category 1 to 5) and/or are capable of cycling 2.5 h in a laboratory setting (using their own bicycles on Saris training systems).
- Agree to train normally, maintain weight, and avoid the regular use of large-dose vitamin and mineral supplements, herbs, and medications that influence inflammation and immune function (especially Advil, Motrin, aspirin, and similar anti-inflammatory drugs) for the duration of the 6-week study. (Review supplement and medication use with the Research Manager during orientation).
- Categorized as "low risk" using the American College of Sports Medicine screening questionnaire.
- Generally healthy and without chronic disease including cardiovascular disease (e.g., heart disease, stroke), cancer, type 1 and 2 diabetes, rheumatoid arthritis.
Who cannot join
- Inability to comply with study requirements.
- Body weight below 100 pounds.
- Pregnant or breastfeeding.
- Any other concurrent condition which, in the opinion of the primary investigator (PI), would preclude participation in this study or interfere with compliance.
- Current diagnosis of cardiovascular disease, diabetes, or cancer (except for non-melanoma skin cancer).
- History of allergic reactions to blueberries.
Trial locations and contacts
1 site in 1 country.
United States1 site
Appalachian State University Human Performance Lab, North Carolina Research Campus
Kannapolis, North Carolina, 28081
About this study
Official title: Influence of Vitero Supplementation (Rice-Pea-Blueberry Sport Gel Formulation) on Exercise-Induced Oxinflammation
This study is the human clinical trial component of an SBIR grant with Sinnovatek (funded). Cyclists (n=20) will consume a blueberry-protein, blueberry, or placebo supplement for 2 weeks prior to cycling for 2.5 h at high intensity. Washout periods (2 weeks) will separate the 3 trials, and the cyclists will crossover (randomized) to one of the two others supplements for 2 weeks, and then engage in additional 2.5 h cycling bouts. Blood and urine samples will be collected pre- and post-supplementation for each of the 3 trials. Blood samples will also be collected immediately after and 1.5h- and 24h-post-exercise. Blood samples will be analyzed for inflammation and oxidative stress outcomes. Urine samples will be analyzed for blueberry gut-derived phenolics.
Read the detailed description
PURPOSE: To investigate the influence of 2-weeks blueberry, blueberry-protein, versus placebo gel supplementation (randomized, crossover) on oxinflammation markers and blueberry gut-derived phenolics after 2.5 h intensive cycling exercise in 20 subjects.
HYPOTHESIS: We hypothesize that 2-weeks blueberry or blueberry-protein polyphenol (500 mg/day) versus placebo gel supplementation will attenuate post-exercise increases in inflammation and oxidative stress biomarkers.
RESEARCH PROCEDURES The research procedures will be conducted at the Human Performance Laboratory (Room 1201, Plants for Human Health Institute Building, 600 Laureate Way), operated by Appalachian State University at the North Carolina Research Campus (NCRC) in Kannapolis, NC. Subjects will come to the lab for orientation/baseline testing with pre-supplementation blood sample collections, three 2.5 h cycling sessions, and additional lab visits to provide 1-day 7:00 am recovery blood samples) (thus 9 total lab visits). The total amount of time subjects will be asked to volunteer for this study is about 20 hours at the Human Performance Laboratory (over a 10-week period).
Orientation/Baseline Testing (Lab Visit #1) Two weeks prior to the 2.5 h cycling session, subjects will report to the Human Performance Laboratory at approximately 7:00-8:00 am. A blood sample will be collected in an overnight fasted state to coincide with the same time of the day for the post-supplementation blood draw. Study participants will be tested for maximal aerobic capacity (VO2max) during a graded, cycle ergometer test with the Cosmed CPET metabolic device (Cosmed, Rome, Italy). Body composition will be measured with the seca BIA and Bod Pod body composition analyzer (Life Measurement, Concord, CA). Demographic and training histories will be acquired with questionnaires. Gel blueberry, blueberry protein, or placebo supplements will be supplied. 3-day food records will be supplied with thorough instructions. Participants will be given two 24-h urine collection kits with thorough written and oral instruction on collection procedures. The first 24-h urine collection bottle will be collected during the 24-h period immediately after lab visit #1 and turned in the next morning. Supplementation will start right after the urine is turned in. The second 24-h urine collection bottle will be collected during the 24-h period immediately prior to lab visit #2. Subjects will collect every drop of urine in the collection bottle for 24 hours.
2-Week Supplementation Periods Study participants will be randomized to Vitero (rice-pea-blueberry) gel, blueberry gel, and placebo gel trials, with supplements ingested daily for 2-weeks prior to participation in the first 2.5 h cycling session. After a 2-week washout period, participants will repeat all procedures two more times using the counterbalanced supplements.
Vitero (500 mg total blueberry polyphenols per day) or placebo (containing all proximate matched ingredients except for the phytoactive polyphenolics) gels will be consumed with breakfast and lunch. The gels will look identical. The placebo has been formulated in house (NCSU at the Plants for Human Health Institute).
2.5 h Cycling Session (Lab Visit #2) During the 3-day period prior to each of three the 2.5 h cycling sessions, subjects will taper exercise training and ingest a moderate-carbohydrate diet using a food list restricting high fat foods, visible fats, and polyphenols. Subjects will record all food and beverage intake during the 3-day period, with macro- and micro-nutrient intake assessed using the Food Processor dietary analysis software system (ESHA Research, Salem, OR).
Study participants will report to the Human Performance Lab in an overnight fasted state and provide a blood sample, ingest the rice-pea-blueberry, blueberry, or placebo gel with water, and then cycle 2.5h at high intensity (60% watts max) while ingesting water alone (3 ml/kg every 15 minutes). Blood samples will be collected at 0 h, 1.5 h, and 21 h post-exercise.
Testing protocol during the lab sessions with the 2.5 h cycling session:
- 7:00 am: Provide blood sample and delayed onset of muscle soreness (DOMS) rating.
- 7:10 am: Ingest supplements with water.
- 7:30 am: Start 2.5 h cycling session. Subjects are to complete the 2.5 h session at an average of 60% watts max. Subjects will use their own bicycles on Saris trainers with Zwift software. A course with moderate difficulty will be utilized using the Zwift software. Heart rate and rating of perceived exertion (RPE) will be recorded every 30 minutes, and workload (watts) continuously monitored using the Zwift software system. Oxygen consumption, carbon dioxide production, respiratory exchange ratio, and ventilation will be measured using the Cosmed Quark CPET metabolic cart every 30 minutes. The total distance cycled in 2.5 h will be recorded. Subjects will consume 3 ml/kg water every 15 min. No other beverage or food containing energy or nutrients will be allowed during the cycling time sessions.
- ~10:00 am to 11:30 am: Immediate-post-exercise, and 1.5-h recovery blood samples. Blood samples will be taken via venipuncture immediately after completing the cycling session, and then 1.5-h post-exercise. Subjects will be allowed to shower and change clothes. DOMS questionnaire will be administered immediately post-exercise and 1.5-h post-exercise. Subjects will ingest no food or beverage other than water (7 ml/kg during the 1.5 h post-exercise period). Subjects will ingest the supplement gels, and then be allowed to leave the lab. Subjects will be instructed to adhere to the food list requirements, and to keep exercise training intensity moderate.
- 7:00 am, next morning: 21-h blood sample and DOMS rating (Lab visit #3).
Washout/Crossover/Repeat Subjects will engage in a 2-week washout period without supplements, crossover, and then repeat all procedures (Lab visits #4,5,6, and then #7,8,9).
- Conditions
- Inflammatory Response
- Being tested
- Blueberry-protein gel, Blueberry gel, Placebo
- Keywords
- blueberries, exercise, inflammation
- Medical subject headings
- Motor Activity, Inflammation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Blueberry-protein gelDietary supplement
Sport gel with blueberry extract and plant protein.
Blueberry gelDietary supplement
Sport gel with blueberry extract only.
PlaceboDietary supplement
Sport gel without the blueberry extract polyphenols and without protein.
| Study group | Role | What they receive |
|---|---|---|
| Blueberry-protein gel | Experimental | Blueberry polyphenols (1 cup fresh blueberries equivalent) from extract with 20 grams rice-pea protein in a gel. Receives: Dietary Supplement: Blueberry-protein gel |
| Blueberry gel | Active comparator | Blueberry polyphenols (1 cup fresh blueberries equivalent) from extract in a gel. Receives: Dietary Supplement: Blueberry gel |
| Placebo | Placebo comparator | All proximate matched ingredients except for the blueberry polyphenols and plant protein. Receives: Dietary Supplement: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Plasma concentrations of inflammasome ASC oligomers
ASC oligomers are an indicator of inflammasome activation
Measured: Change from pre-study to post-2 weeks supplementation, and immediately post-exercise, and 1.5 hours-, and 24 hours-post-exercise
Secondary outcomes (2)
Plasma concentrations of 4-hydroxynonenal
Oxidative stress measure
Measured: Change from pre-study to post-2 weeks supplementation, and immediately post-exercise, and 1.5 hours-, and 24 hours-post-exercise
Urine concentrations of hippuric acid
Blueberry metabolite
Measured: Change from pre-study to post-2 weeks supplementation, and immediately post-exercise, and 1.5 hours-, and 24 hours-post-exercise
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Oct 2022
- Study start15 Jan 2023
- Primary completion1 Jun 2023
- Study completion1 Jun 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Inflammatory ResponseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- Randomized treatment, double blinded procedures, crossover
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 21 participants (actual)
Sponsor and investigators
- Lead sponsor
- Appalachian State University
- Sponsor type
- University, hospital or other
- Collaborators
- SinnovaTek, North Carolina State University
- Responsible party
- Sponsor
- Investigators
- David C Nieman, DrPH, Principal investigator, Appalachian State Univ
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05596500
- Sponsor's protocol ID
- 22-0013
- Status last verified
- Jun 2023
- First submitted
- 24 Oct 2022
- Last updated
- 9 Jun 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Upon request.
Study at a glance
From the registry record, last updated by the sponsor on 9 Jun 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Influence of Vitero Supplementation (Rice-Pea-Blueberry Sport Gel Formulation) on Exercise-Induced Oxinflammation
- ClinicalTrials.gov ID
- NCT05596500
- Acronym / sponsor ID
- 22-0013
- Conditions
- Inflammatory Response
- Keywords
- blueberries, exercise, inflammation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 21 participants (actual)
- Lead sponsor
- Appalachian State UniversityUniversity, hospital or other
- Collaborators
- SinnovaTek, North Carolina State University
- Study start
- 15 Jan 2023 (actual)
- Primary completion
- 1 Jun 2023 (actual)
- Study completion
- 1 Jun 2023 (actual)
- First posted
- 27 Oct 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is the human clinical trial component of an SBIR grant with Sinnovatek (funded). Cyclists (n=20) will consume a blueberry-protein, blueberry, or placebo supplement for 2 weeks prior to cycling for 2.5 h at high intensity. Washout periods (2 weeks) will separate the 3 trials, and the cyclists will crossover (randomized) to one of the two others supplements for 2 weeks, and then engage in additional 2.5 h cycling bouts. Blood and urine samples will be collected pre- and post-supplementation for each of the 3 trials. Blood samples will also be collected immediately after and 1.5h- and 24h-post-exercise. Blood samples will be analyzed for inflammation and oxidative stress outcomes. Urine samples will be analyzed for blueberry gut-derived phenolics.
Detailed description
PURPOSE: To investigate the influence of 2-weeks blueberry, blueberry-protein, versus placebo gel supplementation (randomized, crossover) on oxinflammation markers and blueberry gut-derived phenolics after 2.5 h intensive cycling exercise in 20 subjects.
HYPOTHESIS: We hypothesize that 2-weeks blueberry or blueberry-protein polyphenol (500 mg/day) versus placebo gel supplementation will attenuate post-exercise increases in inflammation and oxidative stress biomarkers.
RESEARCH PROCEDURES The research procedures will be conducted at the Human Performance Laboratory (Room 1201, Plants for Human Health Institute Building, 600 Laureate Way), operated by Appalachian State University at the North Carolina Research Campus (NCRC) in Kannapolis, NC. Subjects will come to the lab for orientation/baseline testing with pre-supplementation blood sample collections, three 2.5 h cycling sessions, and additional lab visits to provide 1-day 7:00 am recovery blood samples) (thus 9 total lab visits). The total amount of time subjects will be asked to volunteer for this study is about 20 hours at the Human Performance Laboratory (over a 10-week period).
Orientation/Baseline Testing (Lab Visit #1) Two weeks prior to the 2.5 h cycling session, subjects will report to the Human Performance Laboratory at approximately 7:00-8:00 am. A blood sample will be collected in an overnight fasted state to coincide with the same time of the day for the post-supplementation blood draw. Study participants will be tested for maximal aerobic capacity (VO2max) during a graded, cycle ergometer test with the Cosmed CPET metabolic device (Cosmed, Rome, Italy). Body composition will be measured with the seca BIA and Bod Pod body composition analyzer (Life Measurement, Concord, CA). Demographic and training histories will be acquired with questionnaires. Gel blueberry, blueberry protein, or placebo supplements will be supplied. 3-day food records will be supplied with thorough instructions. Participants will be given two 24-h urine collection kits with thorough written and oral instruction on collection procedures. The first 24-h urine collection bottle will be collected during the 24-h period immediately after lab visit #1 and turned in the next morning. Supplementation will start right after the urine is turned in. The second 24-h urine collection bottle will be collected during the 24-h period immediately prior to lab visit #2. Subjects will collect every drop of urine in the collection bottle for 24 hours.
2-Week Supplementation Periods Study participants will be randomized to Vitero (rice-pea-blueberry) gel, blueberry gel, and placebo gel trials, with supplements ingested daily for 2-weeks prior to participation in the first 2.5 h cycling session. After a 2-week washout period, participants will repeat all procedures two more times using the counterbalanced supplements.
Vitero (500 mg total blueberry polyphenols per day) or placebo (containing all proximate matched ingredients except for the phytoactive polyphenolics) gels will be consumed with breakfast and lunch. The gels will look identical. The placebo has been formulated in house (NCSU at the Plants for Human Health Institute).
2.5 h Cycling Session (Lab Visit #2) During the 3-day period prior to each of three the 2.5 h cycling sessions, subjects will taper exercise training and ingest a moderate-carbohydrate diet using a food list restricting high fat foods, visible fats, and polyphenols. Subjects will record all food and beverage intake during the 3-day period, with macro- and micro-nutrient intake assessed using the Food Processor dietary analysis software system (ESHA Research, Salem, OR).
Study participants will report to the Human Performance Lab in an overnight fasted state and provide a blood sample, ingest the rice-pea-blueberry, blueberry, or placebo gel with water, and then cycle 2.5h at high intensity (60% watts max) while ingesting water alone (3 ml/kg every 15 minutes). Blood samples will be collected at 0 h, 1.5 h, and 21 h post-exercise.
Testing protocol during the lab sessions with the 2.5 h cycling session:
- 7:00 am: Provide blood sample and delayed onset of muscle soreness (DOMS) rating.
- 7:10 am: Ingest supplements with water.
- 7:30 am: Start 2.5 h cycling session. Subjects are to complete the 2.5 h session at an average of 60% watts max. Subjects will use their own bicycles on Saris trainers with Zwift software. A course with moderate difficulty will be utilized using the Zwift software. Heart rate and rating of perceived exertion (RPE) will be recorded every 30 minutes, and workload (watts) continuously monitored using the Zwift software system. Oxygen consumption, carbon dioxide production, respiratory exchange ratio, and ventilation will be measured using the Cosmed Quark CPET metabolic cart every 30 minutes. The total distance cycled in 2.5 h will be recorded. Subjects will consume 3 ml/kg water every 15 min. No other beverage or food containing energy or nutrients will be allowed during the cycling time sessions.
- ~10:00 am to 11:30 am: Immediate-post-exercise, and 1.5-h recovery blood samples. Blood samples will be taken via venipuncture immediately after completing the cycling session, and then 1.5-h post-exercise. Subjects will be allowed to shower and change clothes. DOMS questionnaire will be administered immediately post-exercise and 1.5-h post-exercise. Subjects will ingest no food or beverage other than water (7 ml/kg during the 1.5 h post-exercise period). Subjects will ingest the supplement gels, and then be allowed to leave the lab. Subjects will be instructed to adhere to the food list requirements, and to keep exercise training intensity moderate.
- 7:00 am, next morning: 21-h blood sample and DOMS rating (Lab visit #3).
Washout/Crossover/Repeat Subjects will engage in a 2-week washout period without supplements, crossover, and then repeat all procedures (Lab visits #4,5,6, and then #7,8,9).
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind (participant, investigator)
- Number of arms
- 3
- Model description
- Randomized treatment, double blinded procedures, crossover
| Arm | Type | Receives |
|---|---|---|
| Blueberry-protein gel | Experimental | Dietary Supplement: Blueberry-protein gelBlueberry polyphenols (1 cup fresh blueberries equivalent) from extract with 20 grams rice-pea protein in a gel. |
| Blueberry gel | Active comparator | Dietary Supplement: Blueberry gelBlueberry polyphenols (1 cup fresh blueberries equivalent) from extract in a gel. |
| Placebo | Placebo comparator | Dietary Supplement: PlaceboAll proximate matched ingredients except for the blueberry polyphenols and plant protein. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Male or female.
- Ages 18-65 years.
- Non-smoker.
- Regularly compete in road races (category 1 to 5) and/or are capable of cycling 2.5 h in a laboratory setting (using their own bicycles on Saris training systems).
- Agree to train normally, maintain weight, and avoid the regular use of large-dose vitamin and mineral supplements, herbs, and medications that influence inflammation and immune function (especially Advil, Motrin, aspirin, and similar anti-inflammatory drugs) for the duration of the 6-week study. (Review supplement and medication use with the Research Manager during orientation).
Key exclusion criteria (6 listed)
- Inability to comply with study requirements.
- Body weight below 100 pounds.
- Pregnant or breastfeeding.
- Any other concurrent condition which, in the opinion of the primary investigator (PI), would preclude participation in this study or interfere with compliance.
- Current diagnosis of cardiovascular disease, diabetes, or cancer (except for non-melanoma skin cancer).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Blueberry-protein gelSport gel with blueberry extract and plant protein. | Dietary supplement | Blueberry-protein gel |
| Blueberry gelSport gel with blueberry extract only. | Dietary supplement | Blueberry gel |
| PlaceboSport gel without the blueberry extract polyphenols and without protein. | Dietary supplement | Placebo |
Primary outcome
Plasma concentrations of inflammasome ASC oligomers
Time frame: Change from pre-study to post-2 weeks supplementation, and immediately post-exercise, and 1.5 hours-, and 24 hours-post-exercise
ASC oligomers are an indicator of inflammasome activation
2 secondary outcomes
Plasma concentrations of 4-hydroxynonenal
Time frame: Change from pre-study to post-2 weeks supplementation, and immediately post-exercise, and 1.5 hours-, and 24 hours-post-exercise
Urine concentrations of hippuric acid
Time frame: Change from pre-study to post-2 weeks supplementation, and immediately post-exercise, and 1.5 hours-, and 24 hours-post-exercise
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jun 2023.
- Individual participant dataSharing planned: Yes. Upon request.
Related trials for Inflammatory Response
RecruitingObservational study
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Asthma, Atherosclerosis
RecruitingPhase 3
THE ROLE OF PANCREATIC STONE PROTEIN (PSP) AND PSP-GUIDED EARLY MEROPENEM TREATMENT TO MITIGATE SEPSIS RISK AT THE EMERGENCY DEPARTMENT: THE PROMISE DOUBLE BLIND, PHASE III, RANDOMIZED CONTROLLED CLINICAL TRIAL
Sepsis
Not yet recruitingObservational study
Comparison of Sepsis Prediction Algorithms
Sepsis
RecruitingPhase 3
Systematic Adjunction of Vasopressine in Septic Shock
Septic Shock
Not yet recruitingObservational study
Clinical Value of EMR3 in Sepsis Diagnosis, Monitoring, and Prognosis: A Multicenter Prospective Observational Study
Sepsis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
David C Nieman, DrPH principal investigator
Appalachian State Univ
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Blueberry-protein gel and Blueberry gel in people with Inflammatory Response, run by Appalachian State University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Plasma concentrations of inflammasome ASC oligomers (time frame: Change from pre-study to post-2 weeks supplementation, and immediately post-exercise, and 1.5 hours-, and 24 hours-post-exercise). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2023.